Robin Harper Cowie - 10 Nov 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin Harper Cowie
Issuer symbol
BDSX
Transactions as of
10 Nov 2025
Net transactions value
-$381
Form type
4
Filing time
13 Nov 2025, 16:53:31 UTC
Previous filing
14 Aug 2025
Next filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cowie Robin Harper CFO, Sec'y & Treasurer 919 WEST DILLON RD, LOUISVILLE /s/ Robin Harper Cowie 13 Nov 2025 0001827690

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +158 +1.2% 13,197 10 Nov 2025 Direct F1, F2, F3
transaction BDSX Common Stock Sale $381 -50 -0.38% $7.62 13,147 10 Nov 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -158 -50% $0.000000 157 10 Nov 2025 Common Stock 158 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").
F2 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3 Includes 500 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.
F4 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F5 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.